Klivira
Request demo

Streamlining Ocrevus Prior Authorization for Orthopedics

Managing Ocrevus prior authorization for orthopedics requires a nuanced approach, integrating neurological patient profiles with orthopedic clinical necessity criteria. Klivira streamlines this complex PA workflow.

While Ocrevus (ocrelizumab) is a targeted therapy for multiple sclerosis (MS) and primary progressive MS, orthopedic practices frequently encounter patients receiving this medication who require prior authorization for orthopedic procedures, advanced imaging, or durable medical equipment (DME). Managing prior authorizations for these patients presents unique challenges, as the patient's overall health status and concomitant medications must be factored into clinical necessity reviews for orthopedic interventions.

Navigating Ocrevus Prior Authorization in Orthopedic Care

Patients undergoing Ocrevus treatment for MS often experience orthopedic complications, such as falls leading to fractures, spasticity impacting joint health, or mobility issues requiring assistive devices. These scenarios necessitate orthopedic interventions, from advanced imaging to complex surgeries. The prior authorization process for these orthopedic services must meticulously consider the patient's overall clinical picture, including their MS diagnosis and Ocrevus regimen, to ensure approvals align with their specific needs and payer medical policies.

Orthopedic PA Triggers Relevant for Patients on Ocrevus

For patients on Ocrevus, common orthopedic prior authorization triggers include advanced imaging like MRI of the spine and joints, major joint replacement (e.g., total knee, total hip arthroplasty), spine surgery (e.g., lumbar fusion, decompression), and durable medical equipment (DME) such as specialized bracing or mobility aids. Physical and occupational therapy visits also frequently require PA. These are often driven by MS-related mobility challenges, spasticity, or increased risk of falls and fractures.

Critical Documentation for Orthopedic PA in Patients on Ocrevus

  • Comprehensive conservative-care trial documentation (NSAIDs, physical therapy, injections) tailored to the patient's MS-related limitations.
  • Detailed imaging confirmation (MRI, CT) of advanced joint disease or spinal pathology, correlating findings with current symptoms and neurological status.
  • BMI considerations and documentation for elective joint replacement, acknowledging potential mobility challenges related to MS.
  • Neurological exam findings, including spasticity assessment and functional limitations, to support the clinical necessity of orthopedic interventions.
  • Psychological evaluation documentation for spinal cord stimulator trials, considering the patient's overall health and pain management profile.
  • Documentation of prior surgical history and any unique considerations due to MS or Ocrevus treatment.

Common Prior Authorization Denials and Ocrevus Patient Considerations

Denials for orthopedic prior authorizations often stem from insufficient conservative-care trial documentation, failure to meet BMI criteria for joint replacement, or gaps in imaging-symptom correlation. For patients on Ocrevus, these denials can be compounded by the complexities of their underlying MS. Payer-specific 'appropriate-use criteria' or 'site-of-service mismatch' can also trigger denials, requiring diligent adherence to payer policies and robust clinical justification that accounts for the patient's comprehensive health status.

Klivira's Approach to Streamlining Orthopedic PA for Complex Cases

Klivira's platform is engineered to manage the complexities of prior authorization for patients with intricate medical profiles, including those on Ocrevus requiring orthopedic care. Our system orchestrates multi-step PA cascades common in orthopedics—from imaging to surgery to post-operative DME—and integrates with EMRs via SMART on FHIR to automate the collection of vital clinical data. This includes conservative-care trial duration, BMI, and imaging history, significantly reducing manual effort and accelerating approval timelines for even the most challenging cases.

Frequently asked questions

How does Klivira handle the specific documentation needs for Ocrevus patients requiring orthopedic PA?

Klivira leverages EMR integration to automatically extract relevant clinical data, including conservative-care history, imaging reports, and neurological findings. Our platform is configured to identify and flag documentation requirements specific to orthopedic procedures, ensuring that the patient's MS diagnosis and Ocrevus treatment are appropriately contextualized for payer review.

Can Klivira manage prior authorizations for both the orthopedic procedure and associated DME for Ocrevus patients?

Yes, Klivira is designed to orchestrate the entire PA lifecycle, including multi-step sequences common in orthopedics. This means we can manage the PA for advanced imaging, surgical procedures like joint replacement or spine surgery, and any necessary durable medical equipment (DME) such as braces or mobility aids, ensuring all linked authorizations are tracked and submitted efficiently.

Does Klivira integrate with specialty benefit managers often involved in orthopedic imaging PA?

Klivira's platform includes routing logic to identify whether advanced musculoskeletal imaging requests route to a specialty benefit-management vendor or directly to the payer. This ensures that the correct submission channel is used, aligning with payer-specific requirements and reducing potential delays from misdirected authorizations.

How does Klivira help address common orthopedic PA denials, especially for patients with complex conditions like MS?

Klivira's system helps pre-empt denials by ensuring comprehensive documentation, including detailed conservative-care trials and robust imaging-symptom correlation. For clinical-necessity denials, our platform facilitates efficient peer-to-peer scheduling, enabling orthopedic surgeons to engage directly with payer medical directors with all necessary clinical data readily available.

Related coverage

Other ocrevus prior authorization by payer

Other ocrevus prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo